Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC004498

Drug Information
Name1-Naphthalen-2-yl-piperazine
IndicationNot AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C14H16N2/c1-2-4-13-11-14(6-5-12(13)3-1)16-9-7-15-8-10-16/h1-6,
11,15H,7-10H2
InChIKeyLWLBVIFUVSUSAY-UHFFFAOYSA-N
Canonical SMILESC1CN(CCN1)C2=CC3=CC=CC=C3C=C2    
TargetSerotonin 1a (5-HT1a) receptorInhibitor[1]
Serotonin 1b (5-HT1b) receptorInhibitor[2]
Serotonin 1d (5-HT1d) receptorInhibitor[1]
Serotonin 2a (5-HT2a) receptorInhibitor[1]
Ref 1J Med Chem. 1986 Nov;29(11):2375-80.5-HT1 and 5-HT2 binding characteristics of some quipazine analogues. To Reference
Ref 2J Med Chem. 1997 Nov 21;40(24):3974-8.5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazine. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543